FDA Approves New Generic Abortion Pill as Lawsuit Moves to Missouri
The lawsuit seeks to restrict mifepristone use to seven weeks of pregnancy and impose in-person doctor visit requirements, citing safety concerns and cross-border drug access, attorneys general said.
- A federal judge ruled that the lawsuit against the FDA regarding mifepristone will be moved to Missouri due to a lack of ties to Texas.
- The FDA approved a new generic version of mifepristone, allowing abortions up to 70 days into pregnancy.
- Senator Josh Hawley criticized the FDA's approval, claiming it endangers lives.
- Senator Patty Murray defended mifepristone, stating that the data shows it is safe and effective.
85 Articles
85 Articles
'Complete betrayal': Mike Pence melts down as Trump admin abandons major promise
Former Vice President Mike Pence melted down Thursday after President Donald Trump's administration approved a generic version of an abortion drug, thereby abandoning a key promise to a part of his base. The Food and Drug Administration on Thursday approved a generic version of mifepristone. The age...
Lawmakers Lay Into Trump's FDA After It Quietly Approves New Abortion Pill
Multiple GOP lawmakers blasted the Food and Drug Administration (FDA) following the agency’s greenlighting of a new abortion drug on Thursday. The flurry of criticism comes after the FDA approved of a new abortion pill from the drugmaker Evita Solutions, a company whose public mission is to “seek to normalize abortion care,” and “commit to […]


Another Generic Abortion Pill Approved Amid FDA Safety Review
(MedPage Today) -- The FDA approved a generic version of the abortion drug mifepristone produced by Evita Solutions, according to an agency letter dated Sept. 30. On its website, Evita states its mission is to assist the medical community "in...
FDA approves another generic abortion pill, prompting conservative backlash
Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.
Coverage Details
Bias Distribution
- 52% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium